NCT04679792

Brief Summary

BACKGROUND: Chiari I malformation is a rare disease characterized by cerebellar amygdalae descent under the level of the foramen magnum. It causes troubles in cerebrospinal fluid circulation and direct compression on brainstem, producing characteristic headaches, neurological impairment and syringomyelia. Surgery is the only treatment, indicated when symptomatology exists. However, sometimes patients complaint about atypical symptoms that are difficult to interpret. We would like to study one of these atypical symptoms, gait imbalance, in a pediatric population thanks to a computerized dynamic posturography (Equitest®). METHOD: infants from 6 to 18 years of age presenting a radiologically confirmed Chiari I malformation will be included in the study. We will compare posturographic results of patients which will be operated on with the results of the patients which will not; furthermore, we will compare preoperative and postoperative results in operated patients. RESULTS: 19 patients have been enrolled in the study, and data have been collected for 12 of them. Seven patients belong to operated population. CONCLUSIONS: even if enrolment of the patients is satisfactory, disposable data are not enough to perform statistical analysis and to put forward any conclusion.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 17, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 22, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

December 22, 2020

Status Verified

December 1, 2020

Enrollment Period

2.5 years

First QC Date

December 17, 2020

Last Update Submit

December 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite Equilibrium Score

    Score elaborated by the Equitest posturography

    Operated patients: from first neurosurgical evaluation to 6 months after surgery (totally: 8-12 months). Non operated patients: about 4 months for complete evaluation.

Secondary Outcomes (6)

  • Cranio cervical MRI

    Operated patients: from first neurosurgical evaluation to 6 months after surgery (totally: 8-12 months).

  • Medullary MRI

    Operated patients: from first neurosurgical evaluation to 6 months after surgery (totally: 8-12 months).

  • Apnea syndrome

    Operated patients: from first evaluation to 6 months after surgery (totally: 8-12 months).

  • Clinic

    Operated patients: from first neurosurgical evaluation to 6 months after surgery (totally: 8-12 months).

  • Scoliosis

    Operated patients: from first neurosurgical evaluation to 6 months after surgery (totally: 8-12 months).

  • +1 more secondary outcomes

Study Arms (2)

operated

Patients Under 18 years of age who are operated for Chiari Malformation on the basis of routine neurosurgical assessment.

Diagnostic Test: Dynamic posturography

non operated

Patients Under 18 years of age who are not operated for Chiari Malformation on the basis of routine neurosurgical assessment.

Diagnostic Test: Dynamic posturography

Interventions

Dynamic posturographyDIAGNOSTIC_TEST

Balance evaluation

non operatedoperated

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients aged from 6 to 18 years, received for neurosurgical counseling at our institution with a radiologically confirmed Chiari I malformation and presenting ENT symptomes like dizziness, nystagmus, gait imbalance, motion sickness and Chiari not-related migraines. Patients will be selected for surgery in habitual fashion, indipendently on the study. The patients will be divided into 2 groups: patients who will be operated on and patients who won't be operated on.

You may qualify if:

  • Radiologically confirmed diagnosis of Chiari I malformation (first MRI realized up to 1/01/2018)
  • ENT symptomes (dizziness, nystagmus, gait imbalance, migraines not due to the presence of Chiari Malformation)

You may not qualify if:

  • Lack of cooperation (cerebral palsy, severe behavioral troubles, orthopedic illness, severe visual impairment)
  • Patient's consent for study non obtained.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stella Irene

Vandœuvre-lès-Nancy, Lorraine, 54500, France

RECRUITING

Related Publications (1)

  • Stella I, Remen T, Petel A, Joud A, Klein O, Perrin P. Postural control in Chiari I malformation: protocol for a paediatric prospective, observational cohort - potential role of posturography for surgical indication. BMJ Open. 2022 May 12;12(5):e056647. doi: 10.1136/bmjopen-2021-056647.

MeSH Terms

Conditions

Arnold-Chiari Malformation

Condition Hierarchy (Ancestors)

Neural Tube DefectsNervous System MalformationsNervous System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Perrin Philippe, PhD

    Nancy Regional University Hospital

    STUDY DIRECTOR

Central Study Contacts

Stella Irene, MD

CONTACT

Klein Olivier, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 17, 2020

First Posted

December 22, 2020

Study Start

September 1, 2019

Primary Completion

March 1, 2022

Study Completion

September 1, 2022

Last Updated

December 22, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations